These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28846777)

  • 1. Efficacy of a Fixed Combination of Tetracycline, Chloramphenicol, and Colistimethate Sodium for Treatment of Candida albicans Keratitis.
    Blanco AR; Nostro A; D'Angelo V; D'Arrigo M; Mazzone MG; Marino A
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4292-4298. PubMed ID: 28846777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model.
    Goldblum D; Frueh BE; Sarra GM; Katsoulis K; Zimmerli S
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1359-63. PubMed ID: 15793112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection.
    Gu W; Yu Q; Yu C; Sun S
    J Glob Antimicrob Resist; 2018 Jun; 13():74-80. PubMed ID: 29191612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J; Li S; Gao A; Zhu K; Zhang H
    Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antifungal susceptibility analysis of Candida albicans versus non-albicans Candida corneal isolates.
    Spierer O; Dugar J; Miller D; OʼBrien TP
    Cornea; 2015 May; 34(5):576-9. PubMed ID: 25826327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes as an ocular delivery system of fluconazole: in-vitro studies.
    Habib FS; Fouad EA; Abdel-Rhaman MS; Fathalla D
    Acta Ophthalmol; 2010 Dec; 88(8):901-4. PubMed ID: 19681761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
    Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
    Sun W; Wang D; Yu C; Huang X; Li X; Sun S
    Int J Antimicrob Agents; 2017 Sep; 50(3):399-405. PubMed ID: 28673609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergy of pseudolaric acid B and fluconazole against clinical isolates of Candida albicans.
    Guo N; Ling G; Liang X; Jin J; Fan J; Qiu J; Song Y; Huang N; Wu X; Wang X; Deng X; Deng X; Yu L
    Mycoses; 2011 Sep; 54(5):e400-6. PubMed ID: 21910756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Eugenol Successfully Treats Experimental Candida albicans-Induced Keratitis.
    Hassan HA; Geniady MM; Abdelwahab SF; Abd-Elghany MI; Sarhan HA; Abdelghany AA; Kamel MS; Rodriguez AE; Alio JL
    Ophthalmic Res; 2018; 60(2):69-79. PubMed ID: 29969774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of extemporaneously prepared miconazole eye drops in Candida albicans-induced keratomycosis.
    Gyanfosu L; Koffuor GA; Kyei S; Ababio-Danso B; Peprah-Donkor K; Nyansah WB; Asare F
    Int Ophthalmol; 2018 Oct; 38(5):2089-2100. PubMed ID: 28900810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycotic Efficacy and Safety of a New Cold Corneal Storage Medium by Time-Kill and Toxicity Studies.
    Giurgola L; Gatto C; Parel JM; Miller D; DʼAmato Tóthová J
    Cornea; 2019 Oct; 38(10):1314-1321. PubMed ID: 31335527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
    Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
    J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in response in vivo to amphotericin B among Candida albicans strains.
    O'Day DM; Ray WA; Robinson RD; Head WS; Williams TE
    Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1569-72. PubMed ID: 2016138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes.
    Jackson BE; Mitchell BM; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2535-9. PubMed ID: 17525181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis.
    Matsumoto Y; Murat D; Kojima T; Shimazaki J; Tsubota K
    Br J Ophthalmol; 2011 Oct; 95(10):1406-9. PubMed ID: 21097785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Various Amphotericin B Concentrations on Candida albicans in Cold Storage Conditions.
    Tran KD; Aldrich BT; D'Amato Tóthová J; Skeie JM; Kondratick CM; Giurgola L; Gatto C; Reed CR; Schmidt GA; Terry MA; Greiner MA
    Cornea; 2020 Jan; 39(1):110-117. PubMed ID: 31206398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCOTIC KERATITIS.
    Grover AD; Agarwal KC
    Br J Ophthalmol; 1961 Dec; 45(12):824-7. PubMed ID: 18170745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.